Search
for

    Sort by

    Community Join

    990-1000 / 1000+ results

      community My Results (3 months on Finasteride)

      in Is this regrowth?  385 upvotes 1 year ago
      A 23-year-old shared positive hair regrowth results after using 1mg of oral Finasteride daily for three months, with no side effects reported. The user hopes to continue without adding Minoxidil, as Finasteride alone has been effective.

      community Chinese source for pyrilutamide or ru8841 ?

      in Product  3 upvotes 8 months ago
      The conversation is about finding a reliable Chinese source for pyrilutamide or RU58841, ideally with a third-party Certificate of Analysis from Janoshik Analytical. The user is seeking recommendations for these hair loss treatments.

      community 28M 0.5MG DUT 5MG MIN - PROGRESS PIC & THANKS

      in Progress Pictures  78 upvotes 2 months ago
      A 28-year-old male shares progress on hair loss treatment using 0.5mg dutasteride and 5mg minoxidil, experiencing initial shedding but encouraged by community support. He also uses ketoconazole occasionally based on scalp oiliness.

      community The Upcoming Big 3 in Future..

      in Research/Science  15 upvotes 3 years ago
      Hair loss treatments discussed: GT 20029, Pyrilutamide, Minoxidil, Finasteride, and Dutasteride. Some believe Dutasteride will replace Finasteride.

      community Fin year 3 results/maintainence

      in Progress Pictures  332 upvotes 1 year ago
      A user has used finasteride for three years to maintain hair thickness and is considering adding minoxidil for temple recession. They report no side effects and are satisfied, while others discuss minoxidil's pros and cons and share hair treatment experiences.

      community People's personal thoughts on my treatment.

      in Treatment  8 upvotes 2 years ago
      A 20-year-old with stage 3 hair loss saw good results using Topical Min 5%, Oral Fin 1mg, DHT Blocker Shampoo, and DHT blocking and Vitamin gummy. The doctor advised stopping Fin after six months due to hormone concerns, but the user is hesitant.